ADAMTS13 Activity
Also known as: ADAMTS-13
Use
The ADAMTS13 Activity test assists in diagnosing acquired (idiopathic) or inherited thrombotic thrombocytopenic purpura (TTP), conditions characterized by the deficiency of the von Willebrand factor cleaving protease, known as ADAMTS13. Levels of this enzyme that fall below 10 percent may indicate either Upshaw-Schulman Syndrome or acquired TTP. Mild to moderate deficiencies can be seen in a variety of medical conditions, and recent plasma exchange therapy might elevate the observed ADAMTS13 activity.
Special Instructions
Not provided.
Limitations
This chromogenic assay for ADAMTS13 Activity does not provide FDA clearance or approval and is therefore categorized as a Laboratory Developed Test (LDT). It is critical to separate specimens if multiple tests are ordered simultaneously to maintain specimen integrity, especially given the sensitivity of this test to the appropriate plasma type. Furthermore, the stability constraints (ambient: 2 hours, frozen: 2 weeks) must be strictly adhered to avoid degradation of the sample that might lead to incorrect results.
Methodology
Chromogenic Assay
Biomarkers
ADAMTS13 Activity
Analyte
LOINC Codes
- 53622-7 - vWF Cp Act/Nor PPP Chro
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1 mL
Minimum Volume
0.5 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect in a Lt. blue (sodium citrate) tube. Refer to Specimen Handling at aruplab.com for hemostasis/thrombosis guidelines.
Storage Instructions
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.
Causes for Rejection
Serum, EDTA plasma, clotted or hemolyzed specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 hours |
| Refrigerated | Unacceptable |
| Frozen | 2 weeks |
Other tests from different labs that may be relevant
